| http://www.w3.org/ns/prov#value | - JUPITER, Fla., Aug. 13, 2012 /PRNewswire/ -- Dyadic International, Inc. (Dyadic) (OTC Pink: DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale of enzymes and other proteins for the bioenergy, bio-based chemicals, biopharmaceutical and industrial enzyme industries, today announced financial results for the second quarter and six months ended June 30,
|
